Found 24 matching trials
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer PHASE1 This is a single-arm, multicenter, phase II study designed to evaluate the ...
Show More Location
Multiple Locations
Learn More & Join Trial
ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma PHASE2 This is a single-arm, single-center, exploratory clinical study. The study ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer PHASE2 This is an open-label, multicenter, single-arm Phase 2 clinical trial evalu...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II PHASE2 Biliary tract carcinoma (BTC), including cholangiocarcinoma and gallbladder...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With EGFR-Positive PHASE2 This phase II trial evaluates the combination of Becotatug Vedotin (MRG003)...
Show More Location
Tianjin Medical Unversity Second Hospital
Learn More & Join Trial
Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma PHASE2 This is a phase 2, open-label, single-arm clinical trial evaluating neoadju...
Show More Location
Hospital of Stomatology, Sun Yat-sen University
Learn More & Join Trial
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors PHASE1 There is a significant unmet medical need for effective therapies for pedia...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma PHASE2 Advanced gastric cancer (AGC) and gastroesophageal junction (GEJ) adenocarc...
Show More Location
Multiple Locations
Learn More & Join Trial
Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma PHASE3 This study is a randomized, open-label, multicenter phase III trial designe...
Show More Location
The Fifth Affiliated Hospital,Sun Yat-sen University
Learn More & Join Trial
A Prospective, Exploratory Study of Becotatug Vedotin Plus Putlimab for Neoadjuvant Therapy and Adjuvant Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma PHASE2 This is a prospective, exploratory, non-registration, multi-center clinical...
Show More Location
Jiangsu Cancer Hospital
Learn More & Join Trial